Go back

Court rules embryonic stem cell technologies unpatentable

The European Court of Justice has ruled that any process involving the destruction of an embryo, such as harvesting stem cells, cannot be patented.

The ruling reflects the fact that, under European laws on biotechnology, human embryos cannot be used for industrial or commercial purposes.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.